Mark A. Chambers

4.8k citations

144 papers · 3.5k indexed · h-index 36

Impact in

Infectious Diseases top 0.5%
- Tuberculosis Research and Epidemiology
Microbiology top 1%
- Microbial infections and disease research

Papers in ⓘ

Infectious Diseases 82
- Tuberculosis Research and Epidemiology 79
Microbiology 19
- Microbial infections and disease research 16

Co-authors: R. Glyn Hewinson (44 shared papers)Adam O. Whelan (7 shared papers)Richard J. Delahay (21 shared papers)H. Martin Vordermeier (3 shared papers)Bryce M. Buddle (4 shared papers)Sandrine Lesellier (20 shared papers)Dolores Gavier‐Widén (11 shared papers)Paul Cockle (1 shared paper)
Journals: Vaccine (14 papers)Veterinary Immunology and Immunopathology (8 papers)Infection and Immunity (6 papers)Preventive Veterinary Medicine (5 papers)Geocarto International (5 papers)
Partner nations: United Kingdom United States Ireland

In The Last Decade

Mark A. Chambers

136 papers receiving 3.4k citations

Peers

Countries citing papers authored by Mark A. Chambers

Since Specialization

Citations

This map shows the geographic impact of Mark A. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Chambers more than expected).

Fields of papers citing papers by Mark A. Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Chambers. The network helps show where Mark A. Chambers may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Chambers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Chambers Line = papers co-authored together Mark A. Chambers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Correlation of ESAT-6-Specific Gamma Interferon Production with Pathology in Cattle followingMycobacterium bovisBCG Vaccination against Experimental Bovine Tuberculosis Infection and Immunity ·H. Martin Vordermeier, Mark A. Chambers, Paul Cockle, Adam O. Whelan, Jennifer Simmons, R. Glyn Hewinson	2002	304
2	Animal-side serologic assay for rapid detection of Mycobacterium bovis infection in multiple species of free-ranging wildlife Veterinary Microbiology ·Konstantin P. Lyashchenko, R. A. Greenwald, Javan Esfandiari, Mark A. Chambers, Joaquín Vicente, Christian Gortázar, Nuno Santos, Margarida Correia‐Neves, Bryce M. Buddle, R. Jackson, Daniel J. O’Brien, Stephen M. Schmitt, Mitchell V. Palmer, Richard J. Delahay, W. Ray Waters	2008	113
3	Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review Seminars in Immunopathology ·Dilara Kiran, Brendan K. Podell, Mark A. Chambers, Randall J. Basaraba	2015	97
4	Efficacy and Safety of BCG Vaccine for Control of Tuberculosis in Domestic Livestock and Wildlife Frontiers in Veterinary Science ·Bryce M. Buddle, H. M. Vordermeier, Mark A. Chambers, Lin-Mari de Klerk-Lorist	2018	86
5	Improved serodetection of Mycobacterium bovis infection in badgers (Meles meles) using multiantigen test formats Diagnostic Microbiology and Infectious Disease ·Rena Greenwald, Javan Esfandiari, Sandrine Lesellier, Raymond L. Houghton, J.M. Pollock, Claus Aagaard, Peter Andersen, R. Glyn Hewinson, Mark A. Chambers, Konstantin P. Lyashchenko	2003	81
6	BCG Vaccination Reduces Risk of Tuberculosis Infection in Vaccinated Badgers and Unvaccinated Badger Cubs PLoS ONE ·Stephen P. Carter, Mark A. Chambers, Stephen P. Rushton, Mark Shirley, Pia Schuchert, Stéphane Pietravalle, Alistair Murray, Fiona Rogers, G. Gettinby, Graham Smith, Richard J. Delahay, R. Glyn Hewinson, Robbie A. McDonald	2012	74
7	Use of an Electronic Nose To DiagnoseMycobacterium bovisInfection in Badgers and Cattle Journal of Clinical Microbiology ·Reinhard Fend, R. Geddes, Sandrine Lesellier, H. M. Vordermeier, L.A. Corner, Eamonn Gormley, Eamon Costello, R. Glyn Hewinson, David Marlin, A Woodman, Mark A. Chambers	2005	73
8	Long-term temporal trends and estimated transmission rates forMycobacterium bovisinfection in an undisturbed high-density badger (Meles meles) population Epidemiology and Infection ·Richard J. Delahay, Neil J. Walker, Graham Smith, D. WILKINSON, R. S. CLIFTON-HADLEY, C. L. CHEESEMAN, A. J. TOMLINSON, Mark A. Chambers	2013	65
9	Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis Vaccine ·L.A. Corner, Eamon Costello, Damien O’Meara, Sandrine Lesellier, Frank E. Aldwell, Mahavir Singh, R. Glyn Hewinson, Mark A. Chambers, Eamonn Gormley	2010	64
10	Development and evaluation of a gamma-interferon assay for tuberculosis in badgers (Meles meles) Tuberculosis ·Deanna Dalley, Dipesh Davé, Sandrine Lesellier, Simonette Palmer, T. Crawshaw, R. Glyn Hewinson, Mark A. Chambers	2007	64
11	Pathology of natural Mycobacterium bovis infection in European badgers ( Meles meles ) and its relationship with bacterial excretion Veterinary Record ·Dolores Gavier‐Widén, Mark A. Chambers, N. Palmer, Diane G. Newell, R. Glyn Hewinson	2001	63
12	Validation of the BrockTB Stat-Pak Assay for Detection of Tuberculosis in Eurasian Badgers ( Meles meles ) and Influence of Disease Severity on Diagnostic Accuracy Journal of Clinical Microbiology ·Mark A. Chambers, T. Crawshaw, Sue Waterhouse, Richard J. Delahay, R. Glyn Hewinson, Konstantin P. Lyashchenko	2008	59
13	Antibody bound to the surface antigen MPB83 ofMycobacterium bovisenhances survival against high dose and low dose challenge FEMS Immunology & Medical Microbiology ·Mark A. Chambers, Dolores Gavier-WidÃ©n, R. Glyn Hewinson	2004	58
14	The safety and immunogenicity of Bacillus Calmette-Guérin (BCG) vaccine in European badgers (Meles meles) Veterinary Immunology and Immunopathology ·Sandrine Lesellier, Simonette Palmer, Deanna Dalley, Dipesh Davé, Linda K. Johnson, R. Glyn Hewinson, Mark A. Chambers	2006	57
15	An AC electrokinetic impedance immunosensor for rapid detection of tuberculosis The Analyst ·Haochen Cui, Shanshan Li, Quan Yuan, Ashutosh Wadhwa, Shigetoshi Eda, Mark A. Chambers, Roland T. Ashford, Hongyuan Jiang, Jie Wu	2013	55
16	Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle The Veterinary Journal ·H. M. Vordermeier, Mark A. Chambers, Bryce M. Buddle, J.M. Pollock, R. Glyn Hewinson	2004	54
17	Immunological approaches to the control of tuberculosis in wildlife reservoirs Veterinary Immunology and Immunopathology ·Bryce M. Buddle, Margot A. Skinner, Mark A. Chambers	2000	53
18	RNA Encoding the MPT83 Antigen Induces Protective Immune Responses againstMycobacterium tuberculosisInfection Infection and Immunity ·Tian Xue, Evangelos Stavropoulos, Min Yang, Silvia Ragno, Martin Vordermeier, Mark A. Chambers, R. Glyn Hewinson, Douglas B. Lowrie, M. Joseph Colston, Ricardo E. Tascon	2004	53
19	Functional genomics reveals the sole sulphate transporter of the Mycobacterium tuberculosis complex and its relevance to the acquisition of sulphur in vivo Molecular Microbiology ·Esen Wooff, Stephen Michell, Stephen V. Gordon, Mark A. Chambers, Stoyan Bardarov, William R. Jacobs, R. Glyn Hewinson, Paul R. Wheeler	2002	52
20	Protection of Eurasian badgers (Meles meles) from tuberculosis after intra-muscular vaccination with different doses of BCG Vaccine ·Sandrine Lesellier, Si Palmer, Sonya Gowtage-Sequiera, Roland T. Ashford, Deanna Dalley, Dipesh Davé, Ute Weyer, Francisco J. Salguero, Alejandro Núñez, T. Crawshaw, L.A. Corner, R. Glyn Hewinson, Mark A. Chambers	2011	49

About Mark A. Chambers

Mark A. Chambers is a scholar working on Infectious Diseases, Microbiology, Immunology, Epidemiology and Agronomy and Crop Science, having authored 144 papers that have together received 3.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (79 papers), Mycobacterium research and diagnosis (58 papers), Immune responses and vaccinations (31 papers), Microbial infections and disease research (16 papers), Immune Response and Inflammation (16 papers), Animal Disease Management and Epidemiology (10 papers), vaccines and immunoinformatics approaches (10 papers) and Advanced Chemical Sensor Technologies (8 papers). The work is most often cited by research in Infectious Diseases (2.3k citations), Microbiology (454 citations), Epidemiology (1.8k citations), Immunology (963 citations) and Agronomy and Crop Science (433 citations). Mark A. Chambers has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include R. Glyn Hewinson, Adam O. Whelan, Richard J. Delahay, H. Martin Vordermeier, Bryce M. Buddle, Sandrine Lesellier, Dolores Gavier‐Widén, Paul Cockle, Konstantin P. Lyashchenko and Deanna Dalley. Their work appears in journals such as Vaccine, Veterinary Immunology and Immunopathology, Infection and Immunity, Preventive Veterinary Medicine and Geocarto International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact